A Study to Evaluate the Effect of add-on Pioglitazone or Dapagliflozin in Participants With Type 2 Diabetes Mellitus Inadequately Controlled by DPP-4 Inhibitor and Metformin Therapy
Clinical trial NCT03499704 · COMPLETED
Trial details
- NCT number
- NCT03499704
- Sponsor
- Celltrion Pharm, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-11
- Primary completion
- 2024-01-02
- Enrollment
- 133
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.